CClinicalTrials.gg
Active, not recruitingNCT06749535Updated Dec 27, 2024

The Detection of Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus

An observational study in Diabetes Mellitus, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-12-27.

Sponsored by Superior University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
250
Ages
30 Years to 65 Years
Sex
All
01

Study summary

"Background: Chronic obstructive pulmonary disease (COPD) is an ongoing lung condition caused by damage to the lungs. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. Diabetes can worsen the progression and prognosis of COPD.

Read the detailed description

If inflammation cause in lungs breathing process become disturbed. If damages the air sacs (alveoli) that cause emphysema. COPD mainly starts with asymptomatic patients who do not realize that they have it. It mostly affects older people or middle-aged. Its symptoms become develop slowly but with the time they become worsen, patient change their life style and treatment become helpful to prevent from chronic disease The Detection of Chronic Obstructive Pulmonary Disease in Patients with Diabetes Mellitus.

Methods: The Study design was cross sectional and carried out in hospital, Lahore from July 2024 to Jan 2024. All eligible patients who were Diabetes Mellitus in the study through random sampling technique.

02

Conditions studied

03

In context

Lung Diseases, Obstructive

2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.

This study's enrollment of 250 is above the median of 150 across 639 observational studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Aim is to access the Chronic Obstructive Pulmonary Disease in Patients With Diabetes Mellitus

Inclusion criteria

  • Age: 30-65 years Gender: Both
  • Male and female
  • At least 5-10 year history of Diabetes Mellitus
  • Chronic Obstructive Pulmonary Disease

Exclusion criteria

Exclusion Criteria:

  • Patients who smoke prolong.
  • Patient having other diseased (asthma, lung carcinoma).
  • Patients having Acute Respiratory Distress Syndrome (ARDS)."
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
250 participants (actual)
Patient registry
No

Interventions

  • Radiationgroup 1

    The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.

06

What researchers measure

Primary outcomes

  1. copd

    The aim of my study, we should diagnose diabetes on time. If diabetes mellitus untreated or uncontrolled for a long they directly affect all over the body, mostly they caused chronic disease due to hyperglycemia that damages the blood vessels. Rapture or damages the blood vessels of the lung causes COPD.

    Time frame: 12 Months

07

Study locations

1 site
  • Gulab devi hospital, Ferozepur Rd, Nishtar Town
    Lahore, Punjab, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06749535
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Dec 27, 2024
Start date
Feb 28, 2024
Primary completion
Aug 1, 2024
Completion
Mar 2, 2025 (estimated)
Last update
Dec 27, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion